Resonate Blends, Inc. (KOAN)
- Previous Close
0.0008 - Open
0.0011 - Bid 0.0008 x --
- Ask 0.0011 x --
- Day's Range
0.0011 - 0.0011 - 52 Week Range
0.0006 - 0.0450 - Volume
26,000 - Avg. Volume
2,985,689 - Market Cap (intraday)
110,441 - Beta (5Y Monthly) 3.15
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date May 8, 2025 - May 9, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Apr 10, 1996
- 1y Target Est
--
Resonate Blends, Inc. engages in the discovery, development, and marketing of products designed to mankind. The company focuses on marketing licensed patent-pending natural stem cell mobilizing agents capable of enhancing each individual's ability to mobilize their own adult stem cells from their bone marrow. It also has a license to market a dual acting all natural diet aid designed to help control hunger through normal body signals to the brain and stomach. In addition, the company engages in the research and development activities center on exploring other areas, such as Secretogues that can naturally enhance a person's own growth hormone production and similar all natural bioactive formulations to enhance human performance safely, ethically, and legally; and utilizing known body mechanisms without the use of drugs. Resonate Blends, Inc. is based in North Bergen, New Jersey.
www.resonateblends.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: KOAN
View MorePerformance Overview: KOAN
Trailing total returns as of 5/8/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: KOAN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: KOAN
View MoreValuation Measures
Market Cap
80.32k
Enterprise Value
3.58M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.06
Price/Book (mrq)
--
Enterprise Value/Revenue
2.65
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-145.22%
Return on Assets (ttm)
-68.77%
Return on Equity (ttm)
--
Revenue (ttm)
1.35M
Net Income Avi to Common (ttm)
-1.96M
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
68.24k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-940.14k